- Home
- / Boehringer Ingelheim
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Boehringer Ingelheim financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Revenue
€12.7 B
FY, 2023
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 8.9B | 10.2B | 12.7B |
| Cost of goods sold | 3.0B | 3.3B | 4.0B |
| Gross profit | 6.0B | 6.9B | 8.7B |
| Gross profit margin, % | 66.9% | 67.7% | 68.4% |
| General and administrative expense | 262.4M | 286.2M | 288.6M |
| Operating expense total | 6.0B | 7.1B | 7.6B |
| Depreciation and amortization | 51.7M | 109.2M | 83.7M |
| EBIT | 1.3B | 1.2B | 4.5B |
| EBIT margin, % | 14.8% | 11.3% | 35.5% |
| Investment income | 9.2M | 11.1M | 10.2M |
| Interest income | 21.3M | 5.8M | 36.8M |
| Interest expense | 46.8M | 18.3M | 6.6M |
| Pre tax profit | 2.2B | 2.2B | 5.8B |
| Income tax expense | 682.0K | ||
| Net Income | 2.2B | 2.2B | 5.8B |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |